In one such study, the authors suggested that although SP-A and SP-D serum levels in COVID-19 patients were higher than in healthy individuals, these levels might drop again in very advanced disease due to alveolar type II cell destruction [38]. The gene discussed is SFTPD; the disease is COVID-19.